PHOENIX – CAIRE will be featuring its FreeStyle Comfort portable oxygen concentrator (POC)at Medtrade West (Booth #828) during Preview Night (April 4) and throughout the day (April 5) on the show floor of the Phoenix Convention Center. CAIRE’s FreeStyle POC excelled in a recent study designed to assess the effectiveness of devices in delivering oxygen to patients.
The study, Comparison of portable oxygen concentrators using a COPD patient simulation model was conducted by: Rachel Culbreth, PhD, MPH, RRT; Robert Murray, MS, RRT; Kyle Brandenberger, PhD; Douglas S. Gardenhire, EdD, RRT, RRT-NPS, FAARC with the Department of Respiratory Therapy, Byrdine F. Lewis College of Nursing and Health Professions at Georgia State University in Atlanta.
“Portable oxygen concentrators are intended to allow patients to maintain a more active lifestyle despite the constraints which COPD or other respiratory conditions might introduce,” said Barry Hassett, vice president of Global Marketing. “The FreeStyle Comfort was specifically designed to optimize oxygen delivery in situations where the patient is not at rest in order to enable them to comfortably enjoy life outside the home. This study confirms that the FreeStyle Comfort meets those objectives — ensuring patients get the oxygen they need when they need it.”
According to a CAIRE press release, the FreeStyle Comfort ultimately outperformed six competitive devices in seven out of eight breathing scenarios through a COPD simulated protocol designed to assess the ability of these devices to effectively deliver oxygen to patients. To view the poster presented at European Respiratory Society, click here. To view the information presented at the American Association for Respiratory Care, click here.
The recent study coincides with the 20th anniversary of the launch of the first POC, specifically LifeStyle Technology developed by CAIRE. “For us, pioneering the first portable oxygen concentrator has long been both a point of pride, and an ongoing incentive to continue to innovate and develop those technologies that will ensure clinically efficacious oxygen delivery and an improved quality of life for all of our users around the world,” said Earl Lawson, CEO of CAIRE Inc
